Traws Pharma, Inc. (TRAW) earnings
TRAW earnings moved a median of -2.98% by the close. Quarterly and annual TRAW reports and results, each read against the price at its own news timestamp. Back to the TRAW overview →
18 measured TRAW earnings events.
Where these TRAW earnings landedvs 16 measured TRAW earnings reactions
| Middle 50% of TRAW earnings reactions | -7.82% to +2.86% |
|---|---|
| Median reaction (to close) | -2.98% |
| Measured reactions | 16 |
Point-in-time · zero look-ahead
Half of the 16 TRAW earnings events with a measured close landed between -7.82% and +2.86%; 31% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Traws Pharma, Inc. For: Jun 30 | SEC filing · Form 10-Q | -3.57% | -3.57% | |
| Form 10-Q Traws Pharma, Inc. For: Mar 31 | SEC filing · Form 10-Q | +4.52% | +21.29% | |
| Form 10-K/A Traws Pharma, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | +4.93% | |
| Form 10-K Traws Pharma, Inc. For: Dec 31 | SEC filing · Form 10-K | -5.60% | -3.20% | |
| Form NT 10-K Traws Pharma, Inc. For: Dec 31 | SEC filing · Form NT | -3.89% | -7.78% | |
| Form 10-Q Traws Pharma, Inc. For: Sep 30 | SEC filing · Form 10-Q | -1.22% | — | |
| Traws Pharma Reports Third Quarter 2025 Results and Business Highlights | Press release | -1.22% | — | |
| Form 10-Q Traws Pharma, Inc. For: Jun 30 | SEC filing · Form 10-Q | -5.05% | -13.83% | |
| Traws Pharma Reports Second Quarter 2025 Results and Business Highlights | Press release | -5.05% | -13.83% | |
| Traws Pharma to Report Second Quarter 2025 Financial Results on Thursday, August 14, 2025 | Press release | +1.32% | -0.66% | |
| Form 10-Q Traws Pharma, Inc. For: Mar 31 | SEC filing · Form 10-Q | -3.24% | +10.19% | |
| Traws Pharma Reports First Quarter 2025 Results and Business Highlights | Press release | +3.03% | -11.29% | |
| Form 10-K/A Traws Pharma, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.57% | -2.76% | |
| Form 10-K Traws Pharma, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | -4.46% | |
| Form 10-Q Traws Pharma, Inc. For: Sep 30 | SEC filing · Form 10-Q | — | -7.93% | |
| Form 10-Q Traws Pharma, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +2.86% | |
| Form NT 10-Q Traws Pharma, Inc. For: Jun 30 | SEC filing · Form NT | +0.00% | +2.86% | |
| Traws Pharma Reports First Quarter 2024 Financial Results and Provides Business Update | Press release | +0.00% | -2.64% |
Keep exploring
More TRAW: analyst actions → · SEC filings → · TRAW overview →